Bisantrene may be one of the worlds most tested drugs. It has previously been approved in France for AML, but no-one wanted to use it.
The below is from the race website.
Bisantrene is a small molecule anthracene-based chemotherapeutic that was originally developed by American Cyanamid (Lederle Laboratories) in the 1970s & 1980s with the goal of creating a less cardiotoxic/toxic anthracycline-like chemotherapeutic.
The drug was approved in France for relapsed or refractory (R/R) acute myeloid leukemia (AML) in 1990, however it was not commercialised and was lost to the clinical community for over 30 years due to various merger and acquisition transactions.
So your claims dont seem on point at all.
RAC - Charts & Price Action, page-18023
-
- There are more pages in this discussion • 3,442 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |